Point72 Asset Management L.P. Makes New Investment in National Research Co. (NASDAQ:NRC)

Point72 Asset Management L.P. purchased a new stake in shares of National Research Co. (NASDAQ:NRC) during the 3rd quarter, Holdings Channel.com reports. The fund purchased 3,857 shares of the company’s stock, valued at approximately $88,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. CWM LLC lifted its position in National Research by 889.7% during the 2nd quarter. CWM LLC now owns 1,158 shares of the company’s stock valued at $27,000 after purchasing an additional 1,041 shares during the period. Quarry LP acquired a new position in National Research in the second quarter valued at approximately $54,000. Benjamin F. Edwards & Company Inc. boosted its stake in National Research by 145.6% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 2,783 shares of the company’s stock valued at $64,000 after acquiring an additional 1,650 shares during the last quarter. FMR LLC grew its holdings in National Research by 397.3% during the 3rd quarter. FMR LLC now owns 2,944 shares of the company’s stock worth $67,000 after acquiring an additional 2,352 shares during the period. Finally, Gladius Capital Management LP raised its position in shares of National Research by 164.5% during the 3rd quarter. Gladius Capital Management LP now owns 3,068 shares of the company’s stock valued at $70,000 after acquiring an additional 1,908 shares during the last quarter. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Stock Down 3.7 %

Shares of National Research stock opened at $17.79 on Friday. National Research Co. has a 12 month low of $17.62 and a 12 month high of $42.18. The business has a fifty day simple moving average of $19.16 and a 200 day simple moving average of $21.90. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30. The stock has a market cap of $417.64 million, a PE ratio of 15.74 and a beta of 0.52.

National Research (NASDAQ:NRC) last announced its quarterly earnings results on Friday, October 25th. The company reported $0.24 earnings per share for the quarter. The business had revenue of $35.82 million for the quarter. National Research had a net margin of 18.78% and a return on equity of 67.40%.

National Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date of this dividend is Friday, December 27th. National Research’s dividend payout ratio is currently 42.48%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.